President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
The bodies of Russian mercenary chief Yevgeny Prigozhin and some of his top lieutenants killed in a Russian jet crash on Wednesday were sent to a nearby facility for medical and forensic analysis, according to Russian media.
Political strategist Jonathan Harris breaks down the highlights from Wednesday's first Republican presidential primary debate and how Former President Donald Trump's absence affected the event.
A scowling Donald Trump posed for a mug shot Thursday as he surrendered inside a jail in Atlanta on charges that he illegally schemed to overturn the 2020 election in Georgia, creating a historic and humbling visual underscoring the former president's escalating legal troubles.
Ramaswamy has crept up in recent polls, leading to his position next to Florida Gov. Ron DeSantis at center stage. He quickly took advantage of the spotlight, attacking the other candidates as "super PAC puppets" and drawing them into tit-for-tats that gave him more air time.
The former New York City mayor, charged as former President Donald Trump's chief co-conspirator in a plot to subvert the 2020 election, is charged with Trump and 17 other people under Georgia’s Racketeer Influenced and Corrupt Organizations Act.
The 4-1 ruling Wednesday departs from the court's own decision earlier this year to strike down a similar law from 2021.
A private jet crashed over Russia on Wednesday, killing all 10 people on board, emergency officials said.
Children’s advocacy groups including Fairplay and Common Sense Media are asking the Federal Trade Commission to investigate Google, saying the tech giant serves personalized ads to kids on YouTube despite federal law prohibiting the practice.
A Tennessee judge agreed Wednesday to temporarily block a new rule advanced by state House Republicans that banned the public from holding signs during floor and committee proceedings.
Former President Donald Trump is skipping tonight's GOP primary debate so what will the other candidates do? Political strategist Johnathan Harris weighs in.
